{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T20:06:58Z","timestamp":1772136418736,"version":"3.50.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:00:00Z","timestamp":1765929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:00:00Z","timestamp":1765929600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["CX002498-01A2"],"award-info":[{"award-number":["CX002498-01A2"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["1R01CA247763-01A1"],"award-info":[{"award-number":["1R01CA247763-01A1"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lab Anim"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    There remains a need for animal models with human translatability in lung cancer (LC) research. Findings in pigs can have a substantial impact owing to their similar anatomy and physiology to humans. Here we present a bronchoscopically induced LC model in Oncopigs carrying inducible\n                    <jats:italic>KRAS<\/jats:italic>\n                    <jats:sup>\n                      <jats:italic>G12D<\/jats:italic>\n                    <\/jats:sup>\n                    and\n                    <jats:italic>TP53<\/jats:italic>\n                    <jats:sup>\n                      <jats:italic>R167H<\/jats:italic>\n                    <\/jats:sup>\n                    mutations. A total of 12 Oncopigs underwent 29 injections via flexible bronchoscopy: 18 adenovirus\u2013Cre recombinase gene (AdCre) inductions were performed endobronchially (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u20096) and transbronchially (\n                    <jats:italic>n<\/jats:italic>\n                    \u2009=\u200912), and 11 control injections were performed without AdCre. Oncopigs underwent serial chest CT with clinical follow-up for 29\u2009weeks. Lung and organ tissues underwent histopathology, immunohistochemistry and RNA sequencing with comparative analysis to human LC data. All 18 sites of AdCre injections had lung consolidations on computed tomography imaging. Inductions led to an overall success rate of 77.8%, including both invasive cancer (61.1%) and carcinoma in situ (16.7%). Transbronchial injections led to histopathologic invasive cancer and\/or carcinoma in situ in 11\/12 (91.7%) and invasive cancer in 8\/12 (66.6%). Endobronchial inductions led to invasive cancer in 3\/6 (50%). A soft tissue metastasis was observed in one Oncopig. Immunohistochemistry confirmed the expression of Pan-Cytokeratin (Pan-CK)\n                    <jats:sup>+<\/jats:sup>\n                    in epithelial cancer cells, with macrophage and T cell infiltration in the tumor microenvironment. Transcriptome comparison showed 54.3% overlap with human LC, while KRAS-mutant mouse LC had 29.88% overlap with human LC. The immunocompetent Oncopig model has a high rate of LC following bronchoscopic transbronchial induction. An overlap of the Oncopig LC transcriptome with the human LC transcriptome was noted. This pig model of LC is expected to have high clinical translatability.\n                  <\/jats:p>","DOI":"10.1038\/s41684-025-01650-0","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T10:03:50Z","timestamp":1765965830000},"page":"12-20","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Characterization of a bronchoscopically induced transgenic lung cancer pig model for human translatability"],"prefix":"10.1038","volume":"55","author":[{"given":"Kirtan","family":"Joshi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanve N.","family":"Suvilesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nagabhishek Sirpu","family":"Natesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yariswamy","family":"Manjunath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jared","family":"Coberly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Schlink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey R.","family":"Kunin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6012-4035","authenticated-orcid":false,"given":"Randall S.","family":"Prather","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristin","family":"Whitworth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey N.","family":"Bryan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mojgan","family":"Golzy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murugesan","family":"Raju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Teixeiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhanu P.","family":"Telugu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3425-2356","authenticated-orcid":false,"given":"Jussuf T.","family":"Kaifi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3949-8566","authenticated-orcid":false,"given":"Satyanarayana","family":"Rachagani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,17]]},"reference":[{"key":"1650_CR1","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/2211-5463.13486","volume":"13","author":"R Tanaka","year":"2023","unstructured":"Tanaka, R. et al. A mouse model of lung cancer induced via intranasal injection for anticancer drug screening and evaluation of pathology. FEBS Open Bio 13, 51\u201359 (2023).","journal-title":"FEBS Open Bio"},{"key":"1650_CR2","first-page":"103","volume":"28","author":"R Holliday","year":"1996","unstructured":"Holliday, R. Neoplastic transformation: the contrasting stability of human and mouse cells. Cancer Surv. 28, 103\u2013115 (1996).","journal-title":"Cancer Surv."},{"key":"1650_CR3","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1126\/science.348.6242.1411","volume":"348","author":"J Kaiser","year":"2015","unstructured":"Kaiser, J. The cancer test. Science 348, 1411\u20131413 (2015).","journal-title":"Science"},{"key":"1650_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26153-7","volume":"12","author":"Z Pan","year":"2021","unstructured":"Pan, Z. et al. Pig genome functional annotation enhances the biological interpretation of complex traits and human disease. Nat. Commun. 12, 5848 (2021).","journal-title":"Nat. Commun."},{"key":"1650_CR5","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abd5758","volume":"13","author":"JK Lunney","year":"2021","unstructured":"Lunney, J. K. et al. Importance of the pig as a human biomedical model. Sci. Transl. Med. 13, eabd5758 (2021).","journal-title":"Sci. Transl. Med."},{"key":"1650_CR6","doi-asserted-by":"publisher","first-page":"149","DOI":"10.14740\/wjon1763","volume":"15","author":"K Joshi","year":"2024","unstructured":"Joshi, K. et al. Pigs: large animal preclinical cancer models. World J. Oncol. 15, 149\u2013168 (2024).","journal-title":"World J. Oncol."},{"key":"1650_CR7","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1126\/science.1163600","volume":"321","author":"CS Rogers","year":"2008","unstructured":"Rogers, C. S. et al. Disruption of the CFTR gene produces a model of cystic fibrosis in newborn pigs. Science 321, 1837\u20131841 (2008).","journal-title":"Science"},{"key":"1650_CR8","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41684-019-0246-5","volume":"48","author":"EP Neff","year":"2019","unstructured":"Neff, E. P. Cancer modeling thinks big with the pig. Lab Anim. 48, 75\u201378 (2019).","journal-title":"Lab Anim."},{"key":"1650_CR9","doi-asserted-by":"publisher","first-page":"e0128864","DOI":"10.1371\/journal.pone.0128864","volume":"10","author":"LB Schook","year":"2015","unstructured":"Schook, L. B. et al. A genetic porcine model of cancer. PLoS ONE 10, e0128864 (2015).","journal-title":"PLoS ONE"},{"key":"1650_CR10","doi-asserted-by":"crossref","unstructured":"Chiang, Y.T. et al. The function of the mutant p53-R175H in cancer. Cancers 13, 4088 (2021).","DOI":"10.3390\/cancers13164088"},{"key":"1650_CR11","doi-asserted-by":"publisher","first-page":"4052","DOI":"10.1172\/JCI75447","volume":"124","author":"JC Sieren","year":"2014","unstructured":"Sieren, J. C. et al. Development and translational imaging of a TP53 porcine tumorigenesis model. J. Clin. Invest. 124, 4052\u20134066 (2014).","journal-title":"J. Clin. Invest."},{"key":"1650_CR12","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.trecan.2023.07.010","volume":"9","author":"MN Zeissig","year":"2023","unstructured":"Zeissig, M. N., Ashwood, L. M., Kondrashova, O. & Sutherland, K. D. Next batter up! Targeting cancers with KRAS-G12D mutations. Trends Cancer 9, 955\u2013967 (2023).","journal-title":"Trends Cancer"},{"key":"1650_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-21448-1","volume":"12","author":"D Van Egeren","year":"2022","unstructured":"Van Egeren, D. et al. Genomic analysis of early-stage lung cancer reveals a role for TP53 mutations in distant metastasis. Sci. Rep. 12, 19055 (2022).","journal-title":"Sci. Rep."},{"key":"1650_CR14","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/s41392-021-00780-4","volume":"6","author":"L Huang","year":"2021","unstructured":"Huang, L., Guo, Z., Wang, F. & Fu, L. KRAS mutation: from undruggable to druggable in cancer. Signal Transduct. Target. Ther. 6, 386 (2021).","journal-title":"Signal Transduct. Target. Ther."},{"key":"1650_CR15","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/d41586-024-00879-y","volume":"628","author":"S Mallapaty","year":"2024","unstructured":"Mallapaty, S. & Kozlov, M. First pig kidney transplant in a person: what it means for the future. Nature 628, 13\u201314 (2024).","journal-title":"Nature"},{"key":"1650_CR16","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1038\/s41591-023-02471-9","volume":"29","author":"N Moazami","year":"2023","unstructured":"Moazami, N. et al. Pig-to-human heart xenotransplantation in two recently deceased human recipients. Nat. Med. 29, 1989\u20131997 (2023).","journal-title":"Nat. Med."},{"key":"1650_CR17","doi-asserted-by":"publisher","first-page":"e0239391","DOI":"10.1371\/journal.pone.0239391","volume":"15","author":"FE Boas","year":"2020","unstructured":"Boas, F. E. et al. Induction and characterization of pancreatic cancer in a transgenic pig model. PLoS ONE 15, e0239391 (2020).","journal-title":"PLoS ONE"},{"key":"1650_CR18","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.jvir.2020.09.011","volume":"32","author":"F Nurili","year":"2021","unstructured":"Nurili, F. et al. Transarterial embolization of liver cancer in a transgenic pig model. J. Vasc. Interv. Radiol. 32, 510\u2013517 e513 (2021).","journal-title":"J. Vasc. Interv. Radiol."},{"key":"1650_CR19","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.lungcan.2023.02.013","volume":"178","author":"M Ghosn","year":"2023","unstructured":"Ghosn, M. et al. Induction and preliminary characterization of neoplastic pulmonary nodules in a transgenic pig model. Lung Cancer 178, 157\u2013165 (2023).","journal-title":"Lung Cancer"},{"key":"1650_CR20","first-page":"114","volume":"6","author":"IW Mak","year":"2014","unstructured":"Mak, I. W., Evaniew, N. & Ghert, M. Lost in translation: animal models and clinical trials in cancer treatment. Am. J. Transl. Res. 6, 114\u2013118 (2014).","journal-title":"Am. J. Transl. Res."},{"key":"1650_CR21","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.trecan.2024.01.005","volume":"10","author":"K Joshi","year":"2024","unstructured":"Joshi, K. et al. Benefits and opportunities of the transgenic Oncopig cancer model. Trends Cancer 10, 182\u2013184 (2024).","journal-title":"Trends Cancer"},{"key":"1650_CR22","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/s41586-019-1191-6","volume":"569","author":"K Gabisonia","year":"2019","unstructured":"Gabisonia, K. et al. MicroRNA therapy stimulates uncontrolled cardiac repair after myocardial infarction in pigs. Nature 569, 418\u2013422 (2019).","journal-title":"Nature"},{"key":"1650_CR23","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.ejphar.2015.03.044","volume":"759","author":"SJ Koopmans","year":"2015","unstructured":"Koopmans, S. J. & Schuurman, T. Considerations on pig models for appetite, metabolic syndrome and obese type 2 diabetes: from food intake to metabolic disease. Eur. J. Pharmacol. 759, 231\u2013239 (2015).","journal-title":"Eur. J. Pharmacol."},{"key":"1650_CR24","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.jtho.2016.01.013","volume":"11","author":"A Azpilikueta","year":"2016","unstructured":"Azpilikueta, A. et al. Successful immunotherapy against a transplantable mouse squamous lung carcinoma with anti-PD-1 and anti-CD137 monoclonal antibodies. J. Thorac. Oncol. 11, 524\u2013536 (2016).","journal-title":"J. Thorac. Oncol."},{"key":"1650_CR25","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1002\/1878-0261.12956","volume":"15","author":"I Lakshmanan","year":"2021","unstructured":"Lakshmanan, I. et al. ST6GalNAc-I promotes lung cancer metastasis by altering MUC5AC sialylation. Mol. Oncol. 15, 1866\u20131881 (2021).","journal-title":"Mol. Oncol."},{"key":"1650_CR26","doi-asserted-by":"publisher","first-page":"3906","DOI":"10.1158\/1078-0432.CCR-16-2530","volume":"23","author":"I Lakshmanan","year":"2017","unstructured":"Lakshmanan, I. et al. MUC16 regulates TSPYL5 for lung cancer cell growth and chemoresistance by suppressing p53. Clin. Cancer Res. 23, 3906\u20133917 (2017).","journal-title":"Clin. Cancer Res."},{"key":"1650_CR27","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1097\/JTO.0000000000000459","volume":"10","author":"AF Gazdar","year":"2015","unstructured":"Gazdar, A. F. et al. The comparative pathology of genetically engineered mouse models for neuroendocrine carcinomas of the lung. J. Thorac. Oncol. 10, 553\u2013564 (2015).","journal-title":"J. Thorac. Oncol."},{"key":"1650_CR28","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1200\/JCO.2010.30.8304","volume":"29","author":"K Politi","year":"2011","unstructured":"Politi, K. & Pao, W. How genetically engineered mouse tumor models provide insights into human cancers. J. Clin. Oncol. 29, 2273\u20132281 (2011).","journal-title":"J. Clin. Oncol."},{"key":"1650_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01553-5","volume":"21","author":"KN Suvilesh","year":"2022","unstructured":"Suvilesh, K. N. et al. Tumorigenic circulating tumor cells from xenograft mouse models of non-metastatic NSCLC patients reveal distinct single cell heterogeneity and drug responses. Mol. Cancer 21, 73 (2022).","journal-title":"Mol. Cancer"},{"key":"1650_CR30","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1158\/1535-7163.MCT-10-0209","volume":"9","author":"SJ Gros","year":"2010","unstructured":"Gros, S. J. et al. Effective therapeutic targeting of the overexpressed HER-2 receptor in a highly metastatic orthotopic model of esophageal carcinoma. Mol. Cancer Ther. 9, 2037\u20132045 (2010).","journal-title":"Mol. Cancer Ther."},{"key":"1650_CR31","doi-asserted-by":"publisher","first-page":"397","DOI":"10.21037\/tlcr.2017.08.01","volume":"6","author":"A Lallo","year":"2017","unstructured":"Lallo, A., Schenk, M. W., Frese, K. K., Blackhall, F. & Dive, C. Circulating tumor cells and CDX models as a tool for preclinical drug development. Transl. Lung Cancer Res. 6, 397\u2013408 (2017).","journal-title":"Transl. Lung Cancer Res."},{"key":"1650_CR32","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1038\/nm.3600","volume":"20","author":"CL Hodgkinson","year":"2014","unstructured":"Hodgkinson, C. L. et al. Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer. Nat. Med. 20, 897\u2013903 (2014).","journal-title":"Nat. Med."},{"key":"1650_CR33","doi-asserted-by":"publisher","first-page":"3855","DOI":"10.1158\/1078-0432.CCR-23-3980","volume":"17","author":"KN Suvilesh","year":"2024","unstructured":"Suvilesh, K. N. et al. Targeting AKR1B10 by drug repurposing with epalrestat overcomes chemoresistance in non-small cell lung cancer patient-derived tumor organoids. Clin. Cancer Res. 17, 3855\u20133867 (2024).","journal-title":"Clin. Cancer Res."},{"key":"1650_CR34","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1126\/science.aaw6985","volume":"364","author":"D Tuveson","year":"2019","unstructured":"Tuveson, D. & Clevers, H. Cancer modeling meets human organoid technology. Science 364, 952\u2013955 (2019).","journal-title":"Science"},{"key":"1650_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11867-6","volume":"10","author":"M Kim","year":"2019","unstructured":"Kim, M. et al. Patient-derived lung cancer organoids as in vitro cancer models for therapeutic screening. Nat. Commun. 10, 3991 (2019).","journal-title":"Nat. Commun."},{"key":"1650_CR36","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jneumeth.2017.03.007","volume":"282","author":"M Khoshnevis","year":"2017","unstructured":"Khoshnevis, M. et al. Development of induced glioblastoma by implantation of a human xenograft in Yucatan minipig as a large animal model. J. Neurosci. Methods 282, 61\u201368 (2017).","journal-title":"J. Neurosci. Methods"},{"key":"1650_CR37","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3389\/fimmu.2020.00100","volume":"11","author":"AN Boettcher","year":"2020","unstructured":"Boettcher, A. N. et al. Novel engraftment and T Cell Differentiation of Human Hematopoietic Cells in ART\u2212\/\u2212IL2RG\u2212\/Y SCID pigs. Front. Immunol. 11, 100 (2020).","journal-title":"Front. Immunol."},{"key":"1650_CR38","doi-asserted-by":"publisher","first-page":"e22975","DOI":"10.1096\/fj.202300223R","volume":"37","author":"CR Schaaf","year":"2023","unstructured":"Schaaf, C. R. et al. A LGR5 reporter pig model closely resembles human intestine for improved study of stem cells in disease. FASEB J. 37, e22975 (2023).","journal-title":"FASEB J."},{"key":"1650_CR39","doi-asserted-by":"crossref","unstructured":"Mondal, P. et al. Induction of pancreatic neoplasia in the KRAS\/TP53 Oncopig. Dis. Model. Mech. 16, dmm049699 (2023).","DOI":"10.1242\/dmm.049699"},{"key":"1650_CR40","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.3389\/fimmu.2018.01301","volume":"9","author":"NH Overgaard","year":"2018","unstructured":"Overgaard, N. H. et al. Genetically induced tumors in the oncopig model invoke an antitumor immune response dominated by cytotoxic CD8\u03b2+ T cells and differentiated \u03b3\u03b4 T cells alongside a regulatory response mediated by FOXP3+ T cells and immunoregulatory molecules. Front. Immunol. 9, 1301 (2018).","journal-title":"Front. Immunol."},{"key":"1650_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-14-332","volume":"14","author":"HD Dawson","year":"2013","unstructured":"Dawson, H. D. et al. Structural and functional annotation of the porcine immunome. BMC Genomics 14, 332 (2013).","journal-title":"BMC Genomics"},{"key":"1650_CR42","doi-asserted-by":"publisher","unstructured":"Schilder, B. M. & Skene, N. G. Orthogene: an R package for easy mapping of orthologous genes across hundreds of species. Bioconductor https:\/\/doi.org\/10.18129\/B9.bioc.orthogene (2022).","DOI":"10.18129\/B9.bioc.orthogene"},{"key":"1650_CR43","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1158\/2159-8290.CD-23-0289","volume":"14","author":"Z Li","year":"2024","unstructured":"Li, Z. et al. Alveolar differentiation drives resistance to KRAS inhibition in lung adenocarcinoma. Cancer Discov. 14, 308\u2013325 (2024).","journal-title":"Cancer Discov."},{"key":"1650_CR44","doi-asserted-by":"publisher","first-page":"17224","DOI":"10.1073\/pnas.1413624111","volume":"111","author":"S Lin","year":"2014","unstructured":"Lin, S. et al. Comparison of the transcriptional landscapes between human and mouse tissues. Proc. Natl Acad. Sci. USA 111, 17224\u201317229 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1650_CR45","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1158\/2159-8290.CD-20-0442","volume":"10","author":"MP Zafra","year":"2020","unstructured":"Zafra, M. P. et al. An in vivo Kras allelic series reveals distinct phenotypes of common oncogenic variants. Cancer Discov. 10, 1654\u20131671 (2020).","journal-title":"Cancer Discov."},{"key":"1650_CR46","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/S0140-6736(23)00221-0","volume":"401","author":"AJ de Langen","year":"2023","unstructured":"de Langen, A. J. et al. Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRASG12C mutation: a randomised, open-label, phase 3 trial. Lancet 401, 733\u2013746 (2023).","journal-title":"Lancet"},{"key":"1650_CR47","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3389\/fonc.2017.00190","volume":"7","author":"KM Schachtschneider","year":"2017","unstructured":"Schachtschneider, K. M. et al. The Oncopig cancer model: an innovative large animal translational oncology platform. Front. Oncol. 7, 190 (2017).","journal-title":"Front. Oncol."},{"key":"1650_CR48","doi-asserted-by":"publisher","first-page":"e1004696","DOI":"10.1371\/journal.ppat.1004696","volume":"11","author":"PL Kotha","year":"2015","unstructured":"Kotha, P. L. et al. Adenovirus entry from the apical surface of polarized epithelia is facilitated by the host innate immune response. PLoS Pathog. 11, e1004696 (2015).","journal-title":"PLoS Pathog."},{"key":"1650_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms1391","volume":"2","author":"V Lutschg","year":"2011","unstructured":"Lutschg, V., Boucke, K., Hemmi, S. & Greber, U. F. Chemotactic antiviral cytokines promote infectious apical entry of human adenovirus into polarized epithelial cells. Nat. Commun. 2, 391 (2011).","journal-title":"Nat. Commun."},{"key":"1650_CR50","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/S0006-3495(04)74197-1","volume":"86","author":"HE Davis","year":"2004","unstructured":"Davis, H. E., Rosinski, M., Morgan, J. R. & Yarmush, M. L. Charged polymers modulate retrovirus transduction via membrane charge neutralization and virus aggregation. Biophys. J. 86, 1234\u20131242 (2004).","journal-title":"Biophys. J."},{"key":"1650_CR51","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider, C. A., Rasband, W. S. & Eliceiri, K. W. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 9, 671\u2013675 (2012).","journal-title":"Nat. Methods"}],"container-title":["Lab Animal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41684-025-01650-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41684-025-01650-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41684-025-01650-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T15:01:49Z","timestamp":1766588509000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41684-025-01650-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,17]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["1650"],"URL":"https:\/\/doi.org\/10.1038\/s41684-025-01650-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5054204\/v1","asserted-by":"object"}]},"ISSN":["0093-7355","1548-4475"],"issn-type":[{"value":"0093-7355","type":"print"},{"value":"1548-4475","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,17]]},"assertion":[{"value":"8 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"B.P.T. is a founding member and serves as a consultant for RenOVAte Biosciences Inc. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}